 NAPLES, Fla., Oct. 7, 2021 PRNewswire -- Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming October conferences: A.G.P. 